As of January 22, 2025, Coya Therapeutics (COYA) has a market cap of $94.564 million USD. According to our data, Coya Therapeutics is ranked No.7731 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $94.56 M |
-1.22%
|
Dec 31, 2024 | $95.73 M |
-22.67%
|
Dec 29, 2023 | $0.12 B |
56.40%
|
Dec 30, 2022 | $79.16 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Aadi Bioscience
AADI
|
$73.80 M |
0.000 M
|
USA
|
Sana Biotechnology
SANA
|
$0.78 B |
0.000 M
|
USA
|
Astellas Pharma
4503.T
|
$16.89 B |
-0.120 B
|
Japan
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Market Cap | = | COYA Stock Price | * | COYA Shares Outstanding |
= | $5.66 | * | 16.71 M | |
= | $94.56 M |